CAPECCHI, PIER LEOPOLDO
 Distribuzione geografica
Continente #
NA - Nord America 8.599
EU - Europa 7.150
AS - Asia 1.175
SA - Sud America 15
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
AN - Antartide 1
Totale 16.967
Nazione #
US - Stati Uniti d'America 8.573
GB - Regno Unito 2.342
IE - Irlanda 1.318
CN - Cina 922
IT - Italia 791
SE - Svezia 782
UA - Ucraina 680
DE - Germania 498
FR - Francia 389
FI - Finlandia 186
VN - Vietnam 135
ES - Italia 46
IN - India 40
BE - Belgio 34
RU - Federazione Russa 31
TR - Turchia 29
CA - Canada 22
TH - Thailandia 17
AU - Australia 12
IR - Iran 10
NL - Olanda 10
GR - Grecia 9
BR - Brasile 8
EU - Europa 7
IL - Israele 6
PL - Polonia 5
HK - Hong Kong 4
HR - Croazia 4
CH - Svizzera 3
CL - Cile 3
JP - Giappone 3
MK - Macedonia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AT - Austria 2
BG - Bulgaria 2
DK - Danimarca 2
EG - Egitto 2
IM - Isola di Man 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
KZ - Kazakistan 1
MX - Messico 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 16.967
Città #
Southend 2.190
Fairfield 1.433
Dublin 1.293
Ashburn 754
Chandler 703
Woodbridge 673
Jacksonville 548
Wilmington 535
Houston 527
Seattle 505
Cambridge 463
Ann Arbor 363
Menlo Park 358
Siena 346
Princeton 242
Beijing 223
Nanjing 201
Dong Ket 135
Dearborn 108
San Diego 93
Helsinki 92
New York 88
San Mateo 88
Boardman 78
Nanchang 73
Shanghai 51
Shenyang 51
Florence 45
Málaga 40
Brussels 34
Düsseldorf 34
Hebei 31
Tianjin 30
Changsha 26
Kunming 26
Izmir 25
Lancaster 24
Jiaxing 23
London 23
Norwalk 23
Jinan 22
Falls Church 21
Guangzhou 20
San Francisco 20
Hefei 18
Toronto 18
Fremont 15
Washington 15
Rome 14
Venezia 14
Pune 13
Zhengzhou 13
Mestre 11
Ningbo 11
Redwood City 11
Hangzhou 10
Changchun 9
Lanzhou 9
Milan 8
Taizhou 8
Tappahannock 8
Chicago 7
Fuzhou 7
Hounslow 7
Sacramento 7
Aulla 6
Canberra 6
Delhi 6
Kilburn 6
Paris 6
Phoenix 6
Auburn Hills 5
Petah Tikva 5
Rufina 5
São Paulo 5
Turin 5
Zanjan 5
Bari 4
Grosseto 4
Modena 4
Naples 4
New Bedfont 4
Queens 4
Scandicci 4
Sinalunga 4
Zagreb 4
Amsterdam 3
Anguillara Sabazia 3
Arezzo 3
Ascoli Piceno 3
Athens 3
Bologna 3
Bratislava 3
Campi Bisenzio 3
Cuneo 3
Hong Kong 3
Monte San Savino 3
Ottawa 3
Parabiago 3
Perugia 3
Totale 13.058
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 274
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 238
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 231
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 224
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 222
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 218
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 212
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 209
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 203
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 198
Torsades de Pointes in patients with polymyalgia rheumatica 195
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 194
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 193
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 188
Polyneuropathy with demyelinating changes in Churg–Strauss syndrome: an unusual association 181
Antirheumatic agents in covid-19: is IL-6 the right target? 179
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 177
Peripheral biomarkers' panel for severe COVID-19 patients 176
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 173
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 171
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 170
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 169
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 167
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 165
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 161
Connective tissue diseases and cardiac rhythm disorders: an overview 156
Statins and the joint: multiple targets for a global protection? 156
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 155
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 153
Risk factors for hospital readmission of elderly patients 150
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 147
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 146
The role of P2X7 receptors in tissue fibrosis: a brief review 146
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 145
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 145
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases. 144
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 143
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 143
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 142
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 140
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 140
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 139
Allopurinol prevents ischaemia-dependent haemorheological changes 139
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 138
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 137
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 136
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 135
Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment 135
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure. 134
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 134
Heart failure and chronic kidney disease in a registry of internal medicine wards 134
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 132
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 130
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 130
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 129
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 129
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 128
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 128
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 128
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 126
null 126
Homocysteine and Raynaud’s phenomenon: a review. 126
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 125
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 124
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 123
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 123
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 122
null 122
null 122
null 120
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 119
Familial Mediterranean fever diagnosed in an elderly patient 119
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 117
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 116
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 116
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 115
Human rheumatoid synoviocytes express functional P2X7 receptors 114
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra. 113
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 113
null 113
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts. 112
Pathogenesis of the novel autoimmune-associated long-QT syndrome 112
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 112
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 112
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 111
Cardiac Arrest Risk during Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-Mediated Effects on Potassium Channel Expression 109
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 108
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 107
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 107
Photopheresis immunomodulation after heart transplantation. 106
Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology) 106
null 105
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 104
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 104
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 104
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 103
Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b 102
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in tuscany, Italy 102
Homocysteine and P wave dispersion in patients with heart transplantation 101
Using Peripheral Blood Mononuclear Cells to determine proteome profiles in human end-stage chronic heart disease 100
Totale 14.275
Categoria #
all - tutte 49.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.250 0 0 0 0 0 0 0 0 0 305 492 453
2019/20203.785 418 134 227 543 230 356 423 476 313 331 124 210
2020/20213.042 134 257 92 352 169 340 201 365 321 284 254 273
2021/20222.192 159 283 133 169 159 74 130 96 138 195 220 436
2022/20232.599 163 256 374 381 206 505 74 189 270 56 69 56
2023/20241.958 93 48 176 115 112 621 693 54 26 20 0 0
Totale 17.262